A recent CVS Health/Morning Consult survey of Americans age 18+ found that mental health concerns are continuing to rise among individuals of all backgrounds, especially Black, age 65+, young adult, and LGBTQIA+ respondents.
Of all the communities touched by the COVID-19 pandemic, healthcare professionals (HCPs) are arguably among those most affected. Specialists on the front lines in primary care, critical care, infectious diseases, and pulmonology roles have experienced COVID-19 first hand—often risking their own health and that of their families to help. A new report from Apollo Intelligence provides a barometer on physicians’ sentiments for 2022, and together with other research, frames a wake-up call to medical device and pharma teams in charge of building a brand presence with prescribers.
EVERSANA, a pioneer of next-generation commercial services to the global life sciences industry, and UpScriptHealth, a leading telehealth and virtual prescribing platform serving life sciences companies, announced a strategic partnership to create a direct-to-patient platform that will transform the patient experience to help accelerate access to therapies worldwide.
Pear Therapeutics, Inc. has announced a program to offer patients seeking treatment for substance use disorder (SUD) or opioid use disorder (OUD) access to a telehealth provider through its “find a provider tool”, along with in-person care options.
The COVID-19 pandemic that became evident in the United States in early 2020 had a profound and disruptive effect upon cancer research and treatment, but the lessons learned can be used to improve healthcare delivery in multiple indications, according to the AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care that was released February 9th.
Telehealth boomed during the pandemic, and experts believe that even with the world opening back up, pharma companies will have to continue to shift and strengthen tactics to reach physicians and patients virtually.
The U.S. Centers for Disease Control and Prevention (CDC) said on May 7 that U.S.-bound international air travelers can meet Covid-19 entry requirements using certain self-administered tests.
Doceree Founder and CEO Harshit Jain, MD, discusses how pharma brands can raise the ROI of digital marketing campaigns.
Coegi’s Brittney Monroe looks at how Covid-19 and the shift towards telehealth services have affected marketing strategies for pharmaceutical companies.
The Covid-19 pandemic has forced healthcare systems and physician’s practices to innovate and try new approaches to care delivery, resulting in the explosive growth of telehealth services. But a comprehensive digital solution can involve much more than the video encounters people typically associate with virtual care.